Literature DB >> 4561960

Dapsone acetylation and the treatment of leprosy.

G A Ellard, P T Gammon, H S Helmy, R J Rees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4561960     DOI： 10.1038/239159a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

2.  [Experimental chemotherapy of leprosy].

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Experimental chemotherapy in leprosy.

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

4.  N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.

Authors:  M Blum; D M Grant; A Demierre; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 5.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

6.  Factors influencing the level of dapsone in blood.

Authors:  B Beiguelman; W Pinto; M M El-Guindy; H Krieger
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.